Appili Therapeutics Inc Asset Resilience Ratio

Latest as of March 2022: 0.00%

Appili Therapeutics Inc asset resilience ratio. Appili Therapeutics Inc (APLI) has an Asset Resilience Ratio of 0.00% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Appili Therapeutics Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CA$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

CA$8.28 Million

≈ $5.99 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Appili Therapeutics Inc (2017–2022)

Asset resilience ratio of Appili Therapeutics Inc from 2017 to 2022. This chart shows how Appili Therapeutics Inc's Asset Resilience Ratio has changed over time. Read Appili Therapeutics Inc (APLI) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Appili Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see APLI asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Appili Therapeutics Inc maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Appili Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Appili Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
CSL Ltd AU:CSL	Biotechnology	0.41%
Genmab A/S CO:GMAB	Biotechnology	23.50%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	Biotechnology	1.69%
Abivax SA American Depositary Shares NASDAQ:ABVX	Biotechnology	4.91%
Bachem Holding AG SW:BANB	Biotechnology	0.00%
Viking Therapeutics Inc NASDAQ:VKTX	Biotechnology	72.03%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%

Appili Therapeutics Inc Asset Resilience Ratio by Year (2017–2022)

Appili Therapeutics Inc asset resilience ratio by year from 2017 to 2022. The table below shows the annual Asset Resilience Ratio data for Appili Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-03-31	0.00%	CA$0.00 ≈ $0.00	CA$8.28 Million ≈ $5.99 Million	--
2021-03-31	27.63%	CA$5.06 Million ≈ $3.66 Million	CA$18.32 Million ≈ $13.25 Million	+27.36pp
2020-03-31	0.27%	CA$30.54K ≈ $22.09K	CA$11.17 Million ≈ $8.08 Million	-0.17pp
2019-03-31	0.45%	CA$30.48K ≈ $22.05K	CA$6.84 Million ≈ $4.94 Million	+0.02pp
2018-03-31	0.42%	CA$30.32K ≈ $21.93K	CA$7.19 Million ≈ $5.20 Million	-0.36pp
2017-03-31	0.78%	CA$20.14K ≈ $14.57K	CA$2.57 Million ≈ $1.86 Million	--

pp = percentage points

About Appili Therapeutics Inc

TO:APLI Canada Biotechnology

Market Cap

$464.29K

CA$641.83K CAD

Market Cap Rank

#31103 Global

#1645 in Canada

Share Price

CA$0.01

Change (1 day)

-50.00%

52-Week Range

CA$0.01 - CA$0.03

All Time High

CA$1.87